Immune reconstitution is an important component of successful allogeneic bone marrow transplantation. + cells in patients who developed grades II-IV acute GVHD was low. The number of CD4 + CD29 + T cells had a tendency to be higher in the patients with extensive chronic GVHD than in those without chronic GVHD 2 years after transplantation whereas the number of CD4 + CD45RA + T cells was low in spite of the absence of chronic GVHD. Serum concentration of IgA was lower in patients with extensive chronic GVHD than in those without chronic GVHD at 180 days. The number of CD4 + CD45RA + cells in 10-19-year-old patients was higher than that in 40-49-year-old patients. Response to the Con A and PHA in 10-19-year-old patients was higher than that in older patients at 1 and 2 years. There was no significant difference in the ability of immune reconstitution between related transplant recipients and unrelated transplant recipients. These results suggest that chronic GVHD and age of patients since viral, fungal and bacterial infections contribute significantly to morbidity and mortality after engraftment. In a recent study, fatal opportunistic infections were reported to have occurred in 12-28% of unrelated transplant recipients and 4-15% of related transplant recipients.
since viral, fungal and bacterial infections contribute significantly to morbidity and mortality after engraftment. In a recent study, fatal opportunistic infections were reported to have occurred in 12-28% of unrelated transplant recipients and 4-15% of related transplant recipients. 1 Many studies have analyzed parameters of immune reconstitution after allogeneic transplantation. The number of circulating natural killer (NK) cells, as determined by CD56 expression, rises rapidly 2 and CD8 + T cells return quickly to the normal range and often remain elevated for a long time after transplantation. 3 However, the absolute number of naive CD4 + T cells, evidenced by expression of CD45RA, is depressed following transplantation for over a year, while the recovery of memory CD4 + T cells, as evidenced by expression of CD29, occurs early after transplantation. 4 So, the total number of CD4 + T cells is low until 6 to 12 months after transplantation. There is thus a characteristic inversion of the normal CD4/CD8 ratio. 3, 5 This low number of CD4 + T cells facilitates the occurrence of opportunistic infections.
The response to the T cell mitogens concanavalin A (ConA) and phytohemaglutinin (PHA) normalizes at approximately 6 months after transplantation in patients without chronic GVHD, and more slowly in those with this complication. 6 The response to the B cell mitogen, pokeweed mitogen (PWM), normalizes early following transplantation. The serum concentrations of immunoglobulins IgG and IgM return to values within the normal range by approximately 9 months after transplantation; in contrast, values for serum IgA remain low for years. 7 This decrease of T and B cell function also contributes to the development of opportunistic infections.
In the absence of specific immunosuppression, acute GVHD has little effect on the tempo of immune reconstitution. The apparent abnormalities due to GVHD are seen in chronic GVHD. 7 Patients with chronic GVHD have a reduced capacity to produce naive CD4 + cells. 4 Additionally, both serum and secretory IgA levels are deficient for a long time after transplantation in patients with chronic GVHD. 6, 8 The age of the recipient also affects immune reconstitution. The recovery of the number of CD4 + cells and the response to mitogen in T cells is delayed in adult recipients. 1, 9 Moreover, some studies have shown that the source of donor cells had a significant effect on immune reconstitution because the incidence of opportunistic infections was higher in unrelated transplant recipients. 1, 10 We evaluated immune reconstitution in recipients during 5 years after allogeneic BMT. We also examined the possibility of an association between immune reconstruction and acute GVHD, chronic GVHD, source of donor cells, or age of recipients.
Materials and methods

Patients
We evaluated 91 consecutive adult patients who had undergone allogeneic BMT and engrafted between January 1992 and December 1998. Characteristics of the patients are listed in Table 1 . Prophylaxis of acute GVHD consisted of short-term methotrexate and cyclosporin A in all patients. Patients without evidence of GVHD were begun on tapering cyclosporin A on day 50 with discontinuation of cyclosporin A on day 150. If grade II-IV acute GVHD developed, patients were treated with predonisolone in doses ranging between 1 and 2 mg/kg/day. Patients with extensive chronic GVHD were treated with cyclosporin A and prednisolone. All patients received 5 g of immunoglobulin once a week from day −6 to day 98.
Immune reconstitution data after BMT were collected at August 1999. Twenty-eight patients died during the 5 years after BMT. Forty-seven patients were not contacted 5 years after BMT. We conducted our investigation with the greatest care but missed performing an examination at each point in some patients. So the numbers of patients evaluated at 
Determination of lymphocyte subsets
The subsets of peripheral blood lymphocytes were determined at engraftment (days 21-28), on day 100, and at 1, 2, 3 and 5 years after BMT. Total white blood cell (WBC) counts were determined by an electronic, automatic counter and WBC differential count was determined by microscopic examination. Two-color flow cytometric immunophenotyping was performed to evaluate mononuclear cell subsets, T cells (
Absolute counts for each cell subset were calculated as the product of the absolute WBC count and lymphocyte differential percentage and the cell subset percentage. Normal values of each cell subset were determined from 30 healthy volunteers.
Responses to mitogens and serum immunoglobulin values
Responses to ConA, PHA and PWM were examined as described elsewhere, 11 at engraftment (days 21-28), on day 100, and at 1, 2, 3 and 5 years after BMT. Serum immunoglobulin values were measured on day 100, day 180, and at 1, 2, 3 and 5 years after BMT. Normal values were determined from 30 healthy volunteers.
Statistical analysis
To compare a particular immunologic value in two or more groups according to acute GVHD, chronic GVHD, source of donor cells, or age of recipients on day 100, day 180 and at 1, 2 years after BMT, Mann-Whitney's U test was used. We did not analyze the data at 3 and 5 years statistically because of the small sample sizes of the subgroups.
Results
Lymphocyte recovery
The number of total T cells and CD56
+ cells returned to values near the normal range 1 year after BMT ( Figure 1) ; that of CD4 + T cells remained below the normal range until 5 years after BMT; while that of CD8 + T cells returned to values within the normal range on day 100 after BMT. There was thus a characteristic inversion of the CD4/CD8 ratio up to 5 years after BMT. CD4 + CD45RA + T cells were characteristically low in number until 5 years after BMT, while CD4 + CD29 + T cells returned to values within the normal range at 2 years after BMT.
Responses to mitogens
The response to PHA normalized 1 year after BMT, while that to ConA normalized at 3-5 years after BMT, and the response to PWM was within the normal range throughout the follow-up period (Figure 1 ).
Antibody production
Serum concentrations of immunoglobulins IgG and IgM were within the normal range on day 100 after BMT and remained almost unchanged thereafter. In contrast, the serum concentration of IgA was below the normal range on day 180 and then it increased gradually until the last determination point (Figure 1 ).
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Clinical correlations
We studied the possibility of an association between immune reconstitution and acute GVHD, chronic GVHD, source of donor cells, or age of recipients. Development of acute GVHD did not affect the number of CD4 + , CD8 + , CD4 + CD45RA + or CD4 + CD29 + cells (Figure 2) . However, the number of CD56 + cells in patients who developed grade II-IV acute GVHD was lower than that in patients with grade 0-I acute GVHD on day 100 after BMT (P = 0.013).
The number of CD4 + CD29 + cells in patients who developed extensive chronic GVHD had a tendency to be higher than that in patients without chronic GVHD 2 years after BMT (P = 0.057). The serum value of IgA in patients who developed extensive chronic GVHD was lower than that in patients without chronic GVHD on day 180 after BMT (P = 0.005) (Figure 3 ). The source of donor cells did not affect the number of lymphocytes in any subset, response to mitogens or antibody production ( Figure 4) .
The number of CD4 + CD45RA + cells in patients 10-19 years old was higher than that in patients in the 40-49 year age bracket (P = 0.019) ( Figure 5 ). Response to Con A in patients 10-19 years old was higher than that in patients in the 30-39 (P = 0.012) or 40-49 (P = 0.002) year age brackets at 1 year, and in patients in the 20-29 (P = 0.036), 30-39 (P = 0.027) or 40-49 (P = 0.010) year age brackets at 2 years. Response to PHA in patients 10-19 years old was higher than that in patients 40-49 (P = 0.018) years of age at 1 year, and 30-39 (P = 0.048) or 40-49 (P = 0.015) years of age at 2 years.
Discussion
Immune reconstitution has been carefully evaluated in recipients of allogeneic marrow transplants. It has been a consistent finding that the absolute numbers of CD8 + T cells and NK cells return to values within the normal range within months following BMT. 3 In contrast, CD4 + T cells have been found not to recover completely, even after as long as 2 years following transplantation. This is because CD4 + CD45RA + T cells are depressed for over a year following transplantation while CD4 + CD29 + T cells return to normal levels within months. 4 In the current study, we confirmed the early recovery of CD8 + T cells and NK cells, and found that the low number of CD4 + CD45RA + T cells
Bone Marrow Transplantation and reversal of the CD4/CD8 ratio persisted for 5 years after BMT. It has been shown that serum concentrations of IgG and IgM return to values within the normal range by approximately 9 months after transplantation, whereas that of IgA recovers by 2 to 3 years. 3, 6 The sequence of achieving normal serum levels of specific immunoglobulin isotypes is similar post transplant in children and adults. 12 We verified early recovery of IgG and IgM on day 100 after BMT while the serum concentration of IgA was below the normal range at 6 months and increased gradually thereafter.
In the absence of specific immunosuppression, acute GVHD has little effect on immune reconstitution. 7 In this study, acute GVHD did not affect the populations of CD4 + , CD8 + CD4 + CD45RA + and CD4 + CD29 + T cells, but the number of CD56 + cells was low in patients who developed grade II-IV acute GVHD. As the number of NK cells following autologous transplantation reaches a normal level within 1 month, 13 both acute GVHD and the use of immunosuppressive therapy to control it might contribute to the low number of CD56 + cells. Chronic GVHD slows the rate of immune reconstitution. 6, 7 Patients with chronic GVHD have a reduced capacity to produce naive CD4 + T cells. 4 Seddik et al 14, 15 Bone Marrow Transplantation demonstrated that a specific thymic epithelial injury in recipients with GVHD affected the production of specific CD4 + T cells. Immunosuppressive drugs used to treat chronic GVHD also impede immune recovery. 16 In our study, the number of CD4 + CD45RA + T cells was low in spite of the presence of chronic GVHD. The number of CD4 + CD29 + T cells tended to be higher in the patients with extensive chronic GVHD than in those without chronic GVHD 2 years after BMT. This is consistent with a recent report that the number of CD4 + CD29 + T cells returned to normal in patients with chronic GVHD. 10 Noel et al 6 demonstrated that patients with chronic GVHD had elevated levels of IgG and IgM 6 to 9 months after BMT. In our study, serum concentrations of IgG and IgM were not affected in spite of the presence of chronic GVHD. But the serum concentration of IgA was lower in patients with extensive chronic GVHD than in those without chronic GVHD on day 180 after BMT. Witherspoon et al 17 showed that T cells failed to help their B cell counterparts to produce immunoglobulin after transplantation. In the presence of chronic GVHD, the role of T cells in the production of IgA might be more impaired by chronic GVHD itself and by immunosuppressive therapy. It is unclear why production of IgA is more affected than that of IgG and IgM.
Many studies have shown that the number of CD4 + CD45RA + T cells correlates inversely with the age of the patient. 1, 4, 9, 18 In this study, we also found inverse correlation between the number of CD4 + CD45RA + T cells and the age of the recipient. We found a similar relationship between the response to ConA and PHA and the age of the recipient. Recent studies have shown that the thymus is essential to reconstitute CD4 + CD45RA + T cells after transplantation, by comparing thymectomized recipients and thymus-bearing recipients. 18 Although an enlargement of the thymus after high-dose chemotherapy is observed in younger patients, the thymus of older patients is involuted. 19 Furthermore, GVHD, which is more frequent in older patients, injures the thymus. 20 These factors would result in a lower production of naive CD4
+ T cells and decreased function of T cells in older recipients.
In this study, there were no significant differences in immune reconstitution, regardless of the source of donors. A recent report showed prolonged deficiency of CD4 + and CD8 + T cells in unrelated transplant recipients when compared with related transplant recipients. 1 In that study, T cell-depleted bone marrow was used, while we used unmanipulated bone marrow. This difference might account for the different results we observed, although comparison of recipients of T cell-depleted bone marrow with those of unmanipulated bone marrow showed no difference in immune reconstitution when sibling bone marrow was used. 21 In summary, BMT recipients, especially older patients, have a limited ability to generate naive CD4 + T cells for many years after transplantation. The serum concentration of IgA increased gradually up to 5 years but it was impaired in patients with extensive chronic GVHD. Patients who are older than 30 years and develop extensive chronic GVHD are considered to be at high risk of opportunistic infections and it is advisable to follow them carefully for immune reconstitution. In this study, imbalances in the subgroups were present and they might make it impossible to clarify whether there were any effects of acute or chronic GVHD on T cell reconstitution and any effects of donor type on immune reconstitution. To clarify these problems a larger sample size of the subgroups is needed.
